Cargando…
Exocrine Pancreatic Dysfunction Increases the Risk of New‐Onset Diabetes Mellitus: Results of a Nationwide Cohort Study
It is well established that individuals with diabetes mellitus (DM) may develop exocrine pancreatic dysfunction (EPD) requiring pancreatic enzyme replacement therapy, whereas the converse relationship has been poorly studied. Pancreatitis is a disease that is well suited to investigate the latter as...
Autores principales: | Cho, Jaelim, Scragg, Robert, Pandol, Stephen J., Petrov, Maxim S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877819/ https://www.ncbi.nlm.nih.gov/pubmed/32692901 http://dx.doi.org/10.1111/cts.12837 |
Ejemplares similares
-
Metabolic Trifecta After Pancreatitis: Exocrine Pancreatic Dysfunction, Altered Gut Microbiota, and New-Onset Diabetes
por: Petrov, Maxim S.
Publicado: (2019) -
Which factors determine exocrine pancreatic dysfunction in diabetes mellitus?
por: Altay, Mustafa
Publicado: (2019) -
Pancreatitis, Pancreatic Cancer, and Their Metabolic Sequelae: Projected Burden to 2050
por: Cho, Jaelim, et al.
Publicado: (2020) -
Glucose variability during the early course of acute pancreatitis predicts two‐year probability of new‐onset diabetes: A prospective longitudinal cohort study
por: Bharmal, Sakina H., et al.
Publicado: (2022) -
Pancreatic enzymes and abdominal adipose tissue distribution in new-onset prediabetes/diabetes after acute pancreatitis
por: Ko, Juyeon, et al.
Publicado: (2021)